METTL1 and cancer: Despite current challenges, including substrate specificity, incomplete understanding of its immune regulatory mechanisms, and limited clinical validation, future research integrating multi-omics analyses, animal model studies, and targeted drug development may advance METTL1 from a basic research focus to clinical application, providing new strategies and opportunities for cancer therapy.